RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

GEMAROMA · Gem Aromatics Ltd · Chemical Manufacturing

GEMAROMA · Gem Aromatics Ltd · Chemical Manufacturing

₹141.14+0.8%

As of 05 Nov close

52-week range

52wk low ₹131.0252wk high ₹230.43

38.7% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Profit declined YoY for 2 straight quartersPromoter holding rose this quarter

Revenue (latest Q)

₹99 Cr

Revenue YoY

PAT YoY

-198.6%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

1.9

P/S (TTM)

2.2

Sector P/E

20.6

Dividend yield

0.0%

CompanyP/EP/BNet marginROED/EDiv. yield
GEMAROMA (this stock)Not meaningful (earnings negative over the last 12 months)1.9-3.8%-3.2%0.340.0%
Asian Paints5311.1+12.8%+22.3%0.18+1.1%
Solar Industries India99.626.6+17.6%+31.4%13.68+0.1%
Pidilite Industries61.319.4+17.2%+24.4%0.04+0.7%

Promoter

rising 2q

FII

falling 1q

MF

0.14% (-0.17pp)

falling 1q

Insider trades

DateInsiderTypeQtyValue
04 Jun 2026Yash ParekhBUY85,000₹1.27 Cr
02 Jun 2026Yash ParekhBUY1,43,760₹2.18 Cr

Bulk/block deals

canonicalSymboldatebuy quantitybuyer countdeal strengthdeal types present
GEMAROMA2026-07-0835035968WEAKBULK

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptNeutral20 Aug 2026
View source filing →

Key takeaway: Gem Aromatics Limited reported revenue of INR83 crores on a standalone basis and INR99 crores on a consolidated basis for Q1 FY27, reflecting Y-o-Y growth despite a seasonally softer quarter. Revenue was impacted by supply disruptions in Madagascar affecting clove raw materials, leading to higher costs and lower margins. The company highlighted progress at its Dahej facility under Krystal Ingredients, focusing on expanding non-mint specialty products and higher-value aromatics. New product verticals, including cooling agents (Gemcool 3, 5, 23) and phenol derivatives, are in commercialization phases, with meaningful revenue expected from Q3 FY27 onwards. The company noted challenges with depreciation from capital expenditures at Dahej and higher operating costs, which pressured consolidated profitability. Management emphasized disciplined execution, improving capacity utilization, and customer engagement as priorities. The company also mentioned a Brazil subsidiary to expand Latin American distribution. Forward-looking guidance included ramp-up of new products and margin improvement as production scales, though specific revenue targets were not provided. The earnings call concluded with management reiterating focus on long-term value creation and sustainable growth.

The summary reflects factual reporting of operational and financial developments, challenges, and strategic priorities without overtly positive or negative language.

Sourced from an exchange-filed transcript, dated 20 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed13 Aug 2026
View source filing →

Key takeaway: The investor presentation from Gem Aromatics Limited for Q1FY27 reported year-on-year growth in revenue from operations, despite the quarter being seasonally softer. Management highlighted a focus on utilizing the expanded manufacturing platform at Dahej and scaling new product categories through Krystal Ingredients. The presentation noted progress in customer engagement and product qualification, with an emphasis on converting these opportunities into recurring commercial business. Innovation and R&D were described as central to the long-term strategy, with ongoing efforts in process innovation and product customization. The company is also strengthening its international presence, with plans for a subsidiary in Brazil to enhance distribution in Latin America. Financial performance showed a decline in gross and EBITDA margins due to higher raw material costs and depreciation from capital expenditures. The presentation included updates on new product verticals and anticipated revenue contributions from various products in the upcoming quarters.

The presentation conveyed both growth opportunities and challenges in profitability.

Sourced from an exchange-filed presentation, dated 13 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive26 May 2026
View source filing →

Key takeaway: Management reported that Q4 FY26 marked a quarter of sequential improvement for Gem Aromatics Limited, reflecting a gradual recovery in the operating environment and improved business momentum. The company experienced better clarity on U.S. tariffs, which supported stronger customer engagement and improved price realization. Management highlighted progress at the Dahej greenfield facility, with the commencement of commercial production of Gemcool 5 and Safranal. The Silvassa plant received an EcoVadis Platinum sustainability rating, indicating strong sustainability performance. Financially, revenue from operations for the quarter was INR 112 crores, a 34% sequential growth, while consolidated revenue was INR 110 crores, reflecting a 40% increase. Gross profit and EBITDA also showed significant sequential growth. However, management noted ongoing geopolitical developments impacting raw material prices, particularly for phenol, which could affect near-term production timelines. The company remains focused on improving operational performance and scaling high-value specialty products.

Management emphasized sequential improvement and positive business momentum.

Sourced from an exchange-filed transcript, dated 26 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed21 May 2026
View source filing →

Key takeaway: The investor presentation from Gem Aromatics Limited detailed the company's performance for Q4 and FY26, highlighting a sequential improvement in financial metrics due to better market conditions and customer engagement. Management reported a recovery in both domestic and global demand, aided by clarity on USA tariffs, which contributed to improved revenue and margins. The Silvassa plant received an EcoVadis Platinum sustainability rating, underscoring the company's commitment to responsible manufacturing. However, management noted challenges in the phenol derivatives segment due to geopolitical issues affecting raw material availability and price volatility. Despite these challenges, management expressed optimism about long-term market conditions. Financially, the company reported a consolidated PAT of Rs 1 Cr, recovering from a loss in the previous quarter, while cash PAT improved significantly. The presentation also outlined recent product launches and ongoing investments in capacity expansion.

The presentation conveyed both positive developments and challenges faced by the company.

Sourced from an exchange-filed presentation, dated 21 May 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2025-26201 pages

Gem Aromatics Limited (GEMAROMA) reported positive long-term outlook for FY2025-26, driven by favorable industry fundamentals and expanding specialty ingredients portfolio. The company commissioned its Dahej facility with ₹270 Cr investment, achieving 10,871 MTPA production capacity. Key developments include entry into specialty segments like cooling agents and citral derivatives, with upcoming phenol derivatives. The company emphasizes robust R&D, sustainability, and corporate governance, maintaining compliance with SEBI and other regulations. No material defaults, insolvency proceedings, or audit issues were reported.

  • Commissioned Dahej facility with ₹270 Cr investment and 10,871 MTPA capacity.
  • Expanded into specialty segments including cooling agents, citral derivatives, and upcoming phenol derivatives.
  • Maintained compliance with SEBI regulations and no insolvency proceedings reported.
  • Positive long-term outlook supported by growing demand for specialty ingredients and value-added aroma chemicals.

Key takeaway: Gem Aromatics Limited is well-positioned for growth with strategic investments, expanded product portfolio, and strong compliance, despite external risks in energy and global markets.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 28 Jul 2026View source filing →

Governance disclosures

AI-generated

Needs attention

No item of a kind that needs attention was stored for this company.

Contingent Liability

1 occurrence

Recent (last 12 months)

Annual Report28 Jul 2026 (FY2025-26)· 6 passages
View source filing →

The company has a contingent liability where the amount cannot be reliably estimated, and it is disclosed in the Standalone financial statements without being recognised as a liability.

Related-Party Transaction

1 occurrence

Recent (last 12 months)

Annual Report28 Jul 2026 (FY2025-26)· 2 passages
View source filing →

The proposed candidate, Mr. Dinesh Vasu Thekkepanakkal, is a related party to the company, and his remuneration as a Whole-Time Director is classified as a related party transaction. The Audit Committee approved this remuneration on May 21, 2026.

Open full Signal Dashboard →